rs533055438
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM2_SupportingPP2_ModeratePM3_SupportingPM1PS3_SupportingPP4_ModeratePP3_Strong
This summary comes from the ClinGen Evidence Repository: The c.1316G>A variant in ACADVL has been reported in three individuals with very long chain acyl-CoA dehydrogenase deficiency in the literature with either significantly reduced VLCAD activity or increased C14:1 acylcarnitine levels, two displaying both phenotypes at once (PP4_strong; PMIDs: 31031081, 23480858, 17999356). In these same probands, the variant was detected three times not confirmed in-trans with several different variants including the pathogenic variant c.848T>C (PM3_supporting; PMIDs: 31031081, 23480858, 17999356). Fibroblast analysis and E. coli transfected with constructs harboring the variant both showed significantly deficient enzyme activity (PS3_supporting; PMIDs: 23480858, 17999356). This variant has a MAF of 0.00005012 in the East Asian population (PM2_supporting; https://gnomad.broadinstitute.org). The variant is located in a well-studied Gly-Gly-x-Gly motif which is critical for the protein's dimer interaction with FAD (PM1; PMID:20060901). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (PP3). In summary, this variant meets criteria to be classified as pathogenic for very long chain acyl-CoA dehydrogenase deficiency in an autosomal recessive manner. ACADVL-specific ACMG/AMP criteria applied: PP4; PM3; PS3; PM2; PM1; PP3 LINK:https://erepo.genome.network/evrepo/ui/classification/CA312270/MONDO:0008723/021
Frequency
Consequence
NM_001270447.2 missense
Scores
Clinical Significance
Conservation
Publications
- very long chain acyl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001270447.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACADVL | NM_000018.4 | MANE Select | c.1316G>A | p.Gly439Asp | missense | Exon 13 of 20 | NP_000009.1 | ||
| ACADVL | NM_001270447.2 | c.1385G>A | p.Gly462Asp | missense | Exon 14 of 21 | NP_001257376.1 | |||
| ACADVL | NM_001033859.3 | c.1250G>A | p.Gly417Asp | missense | Exon 12 of 19 | NP_001029031.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACADVL | ENST00000356839.10 | TSL:1 MANE Select | c.1316G>A | p.Gly439Asp | missense | Exon 13 of 20 | ENSP00000349297.5 | ||
| ACADVL | ENST00000350303.9 | TSL:1 | c.1250G>A | p.Gly417Asp | missense | Exon 12 of 19 | ENSP00000344152.5 | ||
| ACADVL | ENST00000543245.6 | TSL:2 | c.1385G>A | p.Gly462Asp | missense | Exon 14 of 21 | ENSP00000438689.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251404 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461818Hom.: 0 Cov.: 33 AF XY: 0.0000385 AC XY: 28AN XY: 727204 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74446 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at